57
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Microencapsulation of drugs by the coacervation technique using ethylcellulose and acrylate-methacrylate copolymer as wall materials

&
Pages 643-649 | Received 01 Mar 1996, Accepted 10 May 1996, Published online: 27 Sep 2008
 

Abstract

In this study, ethylcellulose and acrylate-methacrylate copolymer (Eudragit RL 100®, Eudragit RS 100®) membranes were prepared by using appropriate types and amounts of plasticizers. Thirty percent and 20% of triacetin based on polymer weight were found to be appropriate plasticizers for ethylcellulose membranes and acrylate-methacrylate copolymer membranes, respectively. The ratios of 3:2 and 2:3 Eudragit RL 100®: Eudragit RS 100® also gave transparent and flexible membranes. Cephalexin was chosen as a model drug. The coacervation technique was investigated for the preparation of cephalexin microcapsules. Ethylcellulose and acrylate-methacrylate copolymer corresponding to the above ratios were selected as wall materials of the microcapsules. The effects of core-to-wall ratios on the surface characteristics and dissolution of the microcapsules were also studied. The coacervation technique with ethylcellulose as wall material gave the higher yield (90%) of microcapsules. The release of cephalexin from ethylcellulose walled microcapsules was slow whilst the release from those of acrylate-methacrylate copolymer was faster. The increase of deposition of wall materials due to the decrease of the core-to-wall ratio resulted in a decrease of dissolution rate.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.